Arca
Skip to content
Tools
Tools

Trevo XP ProVue Retriever

Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment. 510(k) K190779, from Stryker (Fremont, CA). Product code POL, class 2.

As of Nov 19, 2026, K190779 is an FDA 510(k) held by Stryker, substantially equivalent on Jun 25, 2019 after 90 days, with 1 recall tied to it in FDA's recall database.

  • Review time: 90 days
  • Recalls: 1
  • Cited as a predicate by: 2 devices

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

1. The Trevo Retriever is indicated for use to restore blood flow in the neurovasculature by removing thrombus for the treatment of acute ischemic stroke to reduce disability in patients with a persistent, proximal anterior circulation, large vessel occlusion, and smaller core infarcts who have first received intravenous tissue plasminogen activator (IV t-PA).

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a predicate

2 later 510(k) summaries name this device as a predicate

Recalls

Recalls FDA ties to K190779, newest first; recall numbers filed together for one problem share a row, and each opens FDA's recall record
StartedRecallStatus
Sep 21, 2020Z-0114-2021Increase in fracture complaints of the flexible, tapered core wire, resulting in stent retriever separation from the core wire during use. The stent retriever can be left behind in the vasculature.Terminated

Other POL clearances

The newest 510(k)s for the same product code; their median review was 153 days; see every POL device

Record

Type
Traditional
Received
Mar 27, 2019
Review panel
Neurology
Regulation
21 CFR 882.5600

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.